ISSN Print: 0893-9675
Volumes:Volume 22, 2017 Volume 21, 2016 Volume 20, 2015 Volume 19, 2014 Volume 18, 2013 Volume 17, 2012 Volume 16, 2011 Volume 15, 2009 Volume 14, 2008 Volume 13, 2007 Volume 12, 2006 Volume 11, 2000 Volume 9, 1998 Volume 8, 1997 Volume 7, 1996 Volume 6, 1995 Volume 5, 1994
Critical Reviews™ in Oncogenesis
New Doctorial Cancer Research:Prostaglandin-Mediated Immune Modulation
The Biotechnology Centre of Oslo and Centre for Molecular Medicine Norway, Nordic EMBL Partnership, University of Oslo; and Department of Gastroenterological Surgery, Akershus University Hospital, N-1478 Lørenskog, Norway
With the relaunch of Critical Reviews in Oncogenesis, a special section called "New Doctorial Cancer Research" was introduced. Here, we provide new Ph.Ds. with the opportunity to present themselves and their work, preferentially followed by a commentary of a senior scientist with knowledge of the study, and as such, attention is also drawn to the work of the research group. In the current issue of CRO, we present two new Ph.Ds. Keep this opportunity in mind when new Ph.Ds. have fulfilled their dissertations. Instructions for submission to the "New Doctorial Cancer Research" section can be found in the general Instructions to Authors of CRO (www.begellhouse.com).
|Begell Digital Portal||Begell Digital Library||eBooks||Journals||References & Proceedings||Research Collections|